Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Goossens

Showing results (11-20 of 103) with videos related to

Pageof 11
Sort By:
Clinics in Liver Disease|November 27, 2013
The impact of obesity and metabolic syndrome on chronic hepatitis CNicolas Goossens, Francesco Negro
Nutrients|September 29, 2017
Translational Aspects of Diet and Non-Alcoholic Fatty Liver DiseaseNicolas Goossens, François R Jornayvaz
Hepatology (Baltimore, Md.)|October 1, 2010
Image of the month. Digital clubbing in association with hepatopulmonary syndromeNicolas Goossens, Deepak Joshi, John O'Grady
Hepatic Oncology|December 1, 2015
Molecular classification of hepatocellular carcinoma: potential therapeutic implicationsNicolas Goossens, Xiaochen Sun, Yujin Hoshida
World Journal of Gastroenterology|October 1, 2015
Molecular prognostic prediction in liver cirrhosisNicolas Goossens, Shigeki Nakagawa, Yujin Hoshida
Journal of Hepatology|June 18, 2013
Severe immune-mediated drug-induced liver injury linked to ibandronate: a case reportNicolas Goossens, Laurent Spahr, Laura Rubbia-Brandt
Current Hepatology Reports|March 25, 2017
Tailored algorithms for hepatocellular carcinoma surveillance: Is one-size-fits-all strategy outdated?Nicolas Goossens, C Billie Bian, Yujin Hoshida
Swiss Medical Weekly|August 14, 2020
Management of hepatocellular carcinoma: SASL expert opinion statementNicolas Goossens, Christian Toso, Markus H Heim
Revue Medicale Suisse|October 21, 2020
[Bacterial infections in the context of chronic liver disease]Konstantinos Cédric Perdikis, Nicolas Goossens, Sebastian Carballo
Expert Review of Precision Medicine and Drug Development|July 19, 2016
Use of big data in drug development for precision medicineRosa S Kim, Nicolas Goossens, Yujin Hoshida
Pageof 11

Showing results (11-20 of 103) with videos related to

Sort By:
Pageof 11
Clinics in Liver Disease|November 27, 2013
The impact of obesity and metabolic syndrome on chronic hepatitis CNicolas Goossens, Francesco Negro
Nutrients|September 29, 2017
Translational Aspects of Diet and Non-Alcoholic Fatty Liver DiseaseNicolas Goossens, François R Jornayvaz
Hepatology (Baltimore, Md.)|October 1, 2010
Image of the month. Digital clubbing in association with hepatopulmonary syndromeNicolas Goossens, Deepak Joshi, John O'Grady
Hepatic Oncology|December 1, 2015
Molecular classification of hepatocellular carcinoma: potential therapeutic implicationsNicolas Goossens, Xiaochen Sun, Yujin Hoshida
World Journal of Gastroenterology|October 1, 2015
Molecular prognostic prediction in liver cirrhosisNicolas Goossens, Shigeki Nakagawa, Yujin Hoshida
Journal of Hepatology|June 18, 2013
Severe immune-mediated drug-induced liver injury linked to ibandronate: a case reportNicolas Goossens, Laurent Spahr, Laura Rubbia-Brandt
Current Hepatology Reports|March 25, 2017
Tailored algorithms for hepatocellular carcinoma surveillance: Is one-size-fits-all strategy outdated?Nicolas Goossens, C Billie Bian, Yujin Hoshida
Swiss Medical Weekly|August 14, 2020
Management of hepatocellular carcinoma: SASL expert opinion statementNicolas Goossens, Christian Toso, Markus H Heim
Revue Medicale Suisse|October 21, 2020
[Bacterial infections in the context of chronic liver disease]Konstantinos Cédric Perdikis, Nicolas Goossens, Sebastian Carballo
Expert Review of Precision Medicine and Drug Development|July 19, 2016
Use of big data in drug development for precision medicineRosa S Kim, Nicolas Goossens, Yujin Hoshida
Pageof 11